*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. The Competition Authority has once again just punished economic players for agreeing to exclusive import rights in overseas territories. The case concerns medical biology products, which are used by hospitals to carry out in vitro diagnostic tests. In this case, an exclusivity clause had been stipulated in the distribution contract concluded between a pharmaceutical laboratory, a manufacturer of medical biology products, and a wholesaler-importer responsible for their distribution on the territory of French Guiana. Since the Lurel Act of 20 November 2012, Article L. 420-2-1 C. com. prohibits, in the communities covered by Article 73 of the Constitution
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.